"Together, we must pray to change hearts and build a culture of life as we advocate for the most vulnerable," said Bishop Daniel E. Thomas of Toledo, Ohio.
Positive CHMP opinion is based on data from the DEVOTE study which evaluated the high dose regimen of nusinersen in treatment-naive participants and those transitioning from the currently approved 12m ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback